Increased ctDNA abundance in the TNBC and HER2+ tumors may be indicative of increased ctDNA release from more aggressive tumors, something seen in a recent study in lung cancer (Abbosh et al. 2017). This evidence concerns the gene ERBB2 and lung carcinoma.